Page last updated: 2024-08-26

diosgenin and verapamil

diosgenin has been researched along with verapamil in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ding, CH; Li, SL; Long, MH; Mao, Q; Shakya, S; Zhu, H; Zhu, SC1
Lee, EK; Lee, MJ; Moon, SY; Park, SK; Yang, WS1

Other Studies

2 other study(ies) available for diosgenin and verapamil

ArticleYear
Study on the pharmacokinetics profiles of polyphyllin I and its bioavailability enhancement through co-administration with P-glycoprotein inhibitors by LC-MS/MS method.
    Journal of pharmaceutical and biomedical analysis, 2015, Mar-25, Volume: 107

    Topics: Administration, Oral; Animals; ATP Binding Cassette Transporter, Subfamily B; Biological Availability; Caco-2 Cells; Cell Line, Tumor; Chromatography, Liquid; Cyclosporine; Diosgenin; Humans; Male; Rats; Rats, Sprague-Dawley; Saponins; Tandem Mass Spectrometry; Verapamil

2015
Diosgenin, an Activator of 1,25D3-MARRS Receptor/ERp57, Attenuates the Effects of TNF-α by Causing ADAM10-Dependent Ectodomain Shedding of TNF Receptor 1.
    Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2017, Volume: 43, Issue:6

    Topics: ADAM10 Protein; Biological Transport; Calcium; Calcium Channels, L-Type; Cell Membrane; Cells, Cultured; Diosgenin; Egtazic Acid; Endothelial Cells; Humans; Intercellular Adhesion Molecule-1; Microscopy, Confocal; Protein Disulfide-Isomerases; Receptors, Tumor Necrosis Factor, Type I; RNA Interference; RNA, Small Interfering; Tumor Necrosis Factor-alpha; Verapamil

2017